H.R. 9661

Expedited Access to Biosimilars Act

Sponsor: Nicholas A. Langworthy · 2 cosponsors

Where it stands

Referred to the House Committee on Energy and Commerce. (Jul 14)

No roll-call votes yet.

No official summary yet.

Sec. 1. Short title

This Act may be cited as the Expedited Access to Biosimilars Act.

Sec. 2. Assessment of pharmacodynamics or efficacy in clinical studies required for licensure of biological products as biosimilar